Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function
Clinical trial NCT04556461 · COMPLETED
Trial details
- NCT number
- NCT04556461
- Sponsor
- Prof. Dr. Stephan Weidinger
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2022-07-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.